Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.77B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.52B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.18B |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$947M |
| 5 |
Zoetis
ZTS
|
+$787M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.39B |
| 2 |
NVIDIA
NVDA
|
+$2.32B |
| 3 |
Microsoft
MSFT
|
+$2.06B |
| 4 |
Apple
AAPL
|
+$1.62B |
| 5 |
Vanguard Total Bond Market
BND
|
+$1.51B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.47% |
| 2 | Financials | 11.66% |
| 3 | Consumer Discretionary | 8.63% |
| 4 | Communication Services | 7.31% |
| 5 | Healthcare | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Travere Therapeutics
TVTX
$5.2B
| $23.2M | ﹤0.01% |
1,568,544
-73,517
| -4% | -$1.22M |
|
2652
Liberty All-Star Equity Fund
USA
$1.79B
| $23.2M | ﹤0.01% |
3,406,432
+121,527
| +4% | +$791K |
|
2653
Schrodinger
SDGR
$1.13B
| $23.2M | ﹤0.01% |
1,152,304
-20,641
| -2% | -$471K |
|
2654
First Trust Growth Strength ETF
FTGS
$1.29B
| $23.1M | ﹤0.01% |
676,790
+50,951
| +8% | +$1.6M |
|
2655
Lesaka Technologies
LSAK
$396M
| $23.1M | ﹤0.01% |
5,147,335
-17,555
| -0.3% | -$76.1K |
|
2656
Greenlight Captial
GLRE
$552M
| $23.1M | ﹤0.01% |
1,605,777
+3,383
| +0.2% | +$46.5K |
|
2657
Goldman Sachs Access Investment Grade Corporate Bond ETF
GIGB
$966M
| $23M | ﹤0.01% |
500,702
-28,639
| -5% | -$1.3M |
|
2658
Ligand Pharmaceuticals
LGND
$5.76B
| $23M | ﹤0.01% |
202,409
-36,683
| -15% | -$3.92M |
|
|
BSJP
2659
DELISTED
Invesco BulletShares 2025 High Yield Corporate Bond ETF
BSJP
| $23M | ﹤0.01% |
996,877
-80,851
| -8% | -$1.86M |
|
2660
Capri Holdings
CPRI
$1.83B
| $23M | ﹤0.01% |
1,296,632
+293,945
| +29% | +$4.84M |
|
2661
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$764M
| $22.9M | ﹤0.01% |
785,996
+78,903
| +11% | +$2.25M |
|
2662
iShares Cybersecurity and Tech ETF
IHAK
$1B
| $22.9M | ﹤0.01% |
430,947
-41,230
| -9% | -$2.05M |
|
2663
Provident Financial Services
PFS
$3.22B
| $22.9M | ﹤0.01% |
1,307,794
+41,756
| +3% | +$693K |
|
2664
Atkore
ATKR
$2.46B
| $22.9M | ﹤0.01% |
324,576
+4,984
| +2% | +$323K |
|
|
GTM
2665
ZoomInfo Technologies
GTM
$973M
| $22.8M | ﹤0.01% |
2,253,615
+147,056
| +7% | +$1.36M |
|
2666
MINISO
MNSO
$3.88B
| $22.8M | ﹤0.01% |
1,251,644
-1,371,744
| -52% | -$24.6M |
|
2667
Banc of California
BANC
$3.03B
| $22.8M | ﹤0.01% |
1,620,184
-296,431
| -15% | -$4.04M |
|
2668
Brink's
BCO
$4.88B
| $22.7M | ﹤0.01% |
254,594
-80,590
| -24% | -$7.01M |
|
2669
Pacira BioSciences
PCRX
$1.04B
| $22.7M | ﹤0.01% |
950,036
-47,570
| -5% | -$1.2M |
|
2670
Nuveen ESG International Developed Markets Equity ETF
NUDM
$707M
| $22.7M | ﹤0.01% |
638,950
-22,552
| -3% | -$752K |
|
2671
Melco Resorts & Entertainment
MLCO
$2.22B
| $22.6M | ﹤0.01% |
3,121,158
+109,486
| +4% | +$636K |
|
2672
Xtrackers MSCI EAFE High Dividend Yield Equity ETF
HDEF
$2.34B
| $22.6M | ﹤0.01% |
781,903
+45,469
| +6% | +$1.27M |
|
|
SEM
2673
DELISTED
Select Medical
SEM
| $22.6M | ﹤0.01% |
1,485,955
+310,914
| +26% | +$4.85M |
|
2674
Hilton Grand Vacations
HGV
$3.62B
| $22.5M | ﹤0.01% |
542,852
+125,057
| +30% | +$4.72M |
|
2675
Kimbell Royalty Partners
KRP
$1.48B
| $22.5M | ﹤0.01% |
1,614,130
-209,274
| -11% | -$2.74M |
|
Similar funds
Morgan Stanley's Q2 2025 Portfolio in Review
As of Q2 2025, Morgan Stanley held 8,401 positions worth $1.54T, up 9.8% from $1.4T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2025 filing shows 313 new, 3,923 increased, 2,951 reduced and 306 closed positions. Its largest new stake was JBS N.V.: 7,554,358 shares worth $110M. The largest sale was UnitedHealth, an estimated $2.39B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q2 2025 buy was JBS N.V.: 7,554,358 shares worth $110M.
- Morgan Stanley added most to Vanguard Short-Term Bond ETF in Q2 2025, an estimated $1.77B increase.
- Morgan Stanley's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $2.39B.
- Morgan Stanley fully exited Discover Financial Services in Q2 2025, selling an estimated $786M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.54T portfolio in Q2 2025.
- Morgan Stanley opened 313 new positions and closed 306 in Q2 2025.
- Morgan Stanley's portfolio value rose 9.8% quarter-over-quarter to $1.54T.
Based on Morgan Stanley's 13F filing for Q2 2025, filed 15 Aug 2025.